Close Menu

NEW YORK – Natera and Illumina have reached a settlement for their patent infringement litigation, have signed a license agreement, and have amended their existing supply agreement, Natera said in a regulatory filing on Tuesday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.